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Abstract
Neural stem cells (NSCs) lose their competency to generate region-specific neuronal populations at an early stage during
embryonic brain development. Here we investigated whether epigenetic modifications can reverse the regional restriction
of mouse adult brain subventricular zone (SVZ) NSCs. Using a variety of chemicals that interfere with DNA methylation and
histone acetylation, we showed that such epigenetic modifications increased neuronal differentiation but did not enable
specific regional patterning, such as midbrain dopaminergic (DA) neuron generation. Only after Oct-4 overexpression did
adult NSCs acquire a pluripotent state that allowed differentiation into midbrain DA neurons. DA neurons derived from
Oct4-reprogrammed NSCs improved behavioural motor deficits in a rat model of Parkinson’s disease (PD) upon intrastriatal
transplantation. Here we report for the first time the successful differentiation of SVZ adult NSCs into functional region-
specific midbrain DA neurons, by means of Oct-4 induced pluripotency.
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Introduction
One of the fundamental questions in the field of regenerative
neuroscience is whether adult forebrain subventricular zone (SVZ)
neural stem cells (NSCs) can efficiently generate neuronal
phenotypes other than their native inhibitory olfactory bulb
(OB) interneuron populations. Adult SVZ NSCs are primarily
fated to generate non-dopaminergic (DA) gamma-amino butyric
acid (GABA)-ergic olfactory bulb (OB) interneurons [1,2,3,4]. This
represents an obstacle to the development of successful therapeutic
strategies for neurodegenerative diseases, since region-specific
phenotypes are warranted for the generation of clinically relevant
neurons by mobilization of endogenous neural precursor cells
(NPCs) after degeneration or lesion.
With respect of cell therapy for Parkinson’s disease (PD), several
pieces of evidence now demonstrate the importance of the
midbrain DA neuronal subtype as a determinant of the functional
impact of cell-based strategies in animal models of PD [5,6]. The
critical challenge is to generate neuronal populations with the
phenotypic and molecular properties of midbrain DA neurons in
order to achieve proper striatal reinnervation. However, there is
still no evidence of the successful manipulation of adult SVZ NSCs
toward a midbrain DA neuronal identity suitable for such clinical
regenerative purposes. In vitro, midbrain DA neurons have only
been efficiently derived from early fetal ventral midbrain and
embryonic stem cells (ESCs) from preimplanted blastocysts of
embryos [7]. On the contrary, adult SVZ NSCs are more
restricted in their capacity to generate neuronal subtypes with a
specific regional identity [1,2,8]. In vivo, different strategies have
been tested in order to promote the proliferation of endogenous
SVZ NPCs, their migration toward the lesioned striatum, and
their differentiation into midbrain DA neurons [9,10,11,12].
However, there is no evidence that such strategies promote the
generation of functional midbrain DA neurons that integrate into
the nigrostriatal DA system [13,14,15].
During development, adult SVZ NSCs lose their competency for
neuronal region-specific patterning and therefore acquire a
restricted temporal and regional specification [16]. Epigenetic
modifications such as histone acetylation and DNA methylation
play an important role in regulating such fate determination [17].
Importantly, DNA methylation and histone acetylation state closely
correlates with NSC multipotency both in vivo and in vitro [18].
Here, we sought to investigate whether chromatin-modifying
agents (such as histone deacetylase inhibitors and demethylating
agents) can regulate the capacity of adult SVZ NSCs to
differentiate into region-specific neuronal subtypes such as
midbrain DA neurons. We found that chromatin-modifying
agents increase neuronal differentiation of adult SVZ NSCs
without altering their capacity to differentiate into region-specific
neuronal phenotypes. Only by Oct4-induced reprogramming
could adult SVZ NSCs re-acquire the competency to differentiate
into multiple neuronal lineages.
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Animals
4–8 week old C57BL/6 mice (Charles River Laboratories) and
B6;129-Gt(ROSA)26Sor
tm1(rtTA*M2)Jae Col1a1
tm2(tetO-Pou5f1)Jae/J
(rTA/Oct4) mice (The Jackson Laboratory) were used in the
study. Female Sprague-Dawley rats with unilateral 6-OHDA
lesions were obtained from Taconic. All animal procedures were
performed in accordance with the guidelines of the National
Institutes of Health and were approved by the Institutional Animal
Care and Use Committee (IACUC) at McLean Hospital, Harvard
Medical School (Mclean IACUC Protocol #09-3/2-6 approved
on 09/16/10).
Primary neural stem cell cultures and differentiation
NSC cultures were established from the lateral ventricular walls
of 4- to 8-week-old female mice, as described [19]. Briefly, the
SVZ was isolated [20] and digested in 0.1% trypsin-EDTA. Cells
were plated at a density of 20 cells/ml in growth medium,
consisting of mouse NeuroCult NSC basal medium, mouse
NeuroCult NSC proliferation supplements, 2 mg/ml heparin,
penicillin [100 U/ml]/streptomycin [100 U/ml], EGF (20 ng/
ml) and bFGF (10 ng/ml) (all from StemCell Technologies). To
analyse cell proliferation, wild-type (n=3) or rTA/Oct4 (n=3)
primary NSCs were plated at 8000 cells/cm
2 in neurosphere
growth medium. After 3–4 days, neurospheres were harvested,
mechanically dissociated, counted and re-plated under the same
culture conditions. For in vitro neurosphere formation assay,
NSCs from wild-type (n=5) and rTA/Oct4 mice (n=5) were
plated in 24-well polyornithine coated plates at a density of
8000 cells/cm
2 in growth medium with or without doxycycline
(DOX) (2 mg/mL; Sigma). Number of neurospheres (diame-
ter$100 mm) was counted 7 days after plating [21].
To induce differentiation, cells were manually dissociated and
plated on glass coverslips coated with 10 mg/mL poly-L-ornithine
and 1 mg/mL laminin at density of <5‘10
5 cells/cm
2. Cells were
first expanded and patterned for 4 days after plating in N2
medium supplemented with FGF2 (10 ng/ml), Shh (500 ng/ml),
and FGF8 (100 ng/ml) (all from R&D Systems). After 4 days, cells
were subsequently differentiated in N2 medium containing
ascorbic acid (AA) (200 mM; Sigma) for 10–14 days. In some
experiments, NSCs were treated with VPA (1 mM, EMD), TSA
(100 nM, EMD), AZA (1 mM, Sigma), BIX-01294 (1 mM, Sigma)
or 100 nM TSA/500 nM AZA for 72 hours and then replated in
differentiation medium containing 1 mM VPA, 100 nM TSA,
1 mM AZA, 1 mM BIX-01294 or 100 nM TSA/500 nM AZA.
After an additional 48 hours, chemicals were withdrawn and
differentiation was carried out as described above. Untreated
NSCs and dimethyl sulfoxide (DMSO)-treated NSCs were used as
control. Three independent experiments were run at least in
triplicate.
Bisulfite sequencing
DNA was isolated with a QIAGEN DNeasy kit. Purified
genomic DNA was denatured and converted with an Epitect kit
QIAGEN. 500 ng of DNA was then bisulfite converted and
purified. Bisulfite sequencing was carried out by Genpathway, Inc.
Bisulfite conversion specific primers were designed using Meth-
Primer. PCR products were cloned into the TOPO-TA vector
(Invitrogen), transformed into bacteria and plated on agarose
plates. Colonies were picked, inserts were PCR amplified using
M13 forward and reverse primers and products were visualized on
a 1% agarose gel. Amplified PCR products were sequenced using
M13 reverse primers. The following primers were used: bisulfite
PCR-forward (GTAATGGTTGTTTTGTTTTGGTTTT), bi-
sulfite PCR-reverse (CCACCCTCTAACCTTAACCTCTAAC).
Generation of NSC-derived iPSCs
NSCs established from 4 week-old rTA-Oct4 transgenic mice
were seeded at a density of 5‘10
5 cells per 6-well plate in growth
medium with DOX (1–2 mg/ml). Forty-eight hours later, cells
were further subcultured on irradiated MEFs (GlobalStem) in ESC
medium (DMEM supplemented with 15% FBS, nonessential
amino acids, L-glutamine, penicillin/streptomycin, b-mercapto-
ethanol, and 1000 U/ml LIF) with DOX (2 mg/ml). In some
conditions, VPA (0.5 mM) was added to ESC medium for 7–10
days. ES-like colonies were mechanically isolated, and individual
cells were dissociated and subsequently replated onto MEFs.
Quantitative Real-Time PCR
Total RNA was extracted with an RNeasy kit (QIAGEN) as
described [22]. The expression level of each gene was normalized
to endogenous b-actin. Fold-change in gene expression was
calculated using 2
2DDCT method [23]. All the results are from
three technical replicates of three independent experiments.
Primer sequences are available on request.
Western-Blot
Cells were lysed in NE-PER Nuclear and Cytoplasmic
Extraction Kit (Pierce) according to the manufacturer’s protocol.
Protein extract (20 mg) was run on a 4%–15% gradient gel (Bio-
Rad). The following primary antibodies were used: Oct-4 (1:200,
Santa Cruz, H-134), b-TubIII (1:1000, Abcam), GFAP (1:1000,
Millipore), GAPDH (1:5000, Millipore).
In vitro differentiation of NPC-derived iPSCs
Cells were harvested by trypsinization and transferred to
bacterial culture dishes in ESC medium without LIF. After 3
days, aggregated cells were plated onto gelatin-coated tissue
culture dishes and incubated for another 7 days. Differentiated
EBs were fixed with 4% paraformaldehyde.
In vitro differentiation of NSC-derived iPSCs into DA
neurons
NPC-derived iPSCs were differentiated into DA neurons using a
previously described protocol [7], with some modifications. iPSCs
(stage 1) were dissociated and plated in bacterial dishes. EBs were
allowed 3 days to form in DMEM containing defined 10% FBS, L-
glutamine (2 mM), 16NEAA, HEPES (10 mM), b-mercaptoeth-
anol (1 mM), penicillin (100 U/ml)/streptomycin (100 g/ml)
(stage 2). EBs were allowed 1 day to attach to tissue culture
dishes, and neuronal precursors were then selected by incubation
in DMEM F-12 medium containing apo-transferrin (50 g/ml),
insulin (5 g/ml), sodium selenite (30 nM), fibronectin (250 ng/ml),
penicillin (100 U/ml)/streptomycin (100 g/ml) for 9–10 days
(stage 3). Cells were subsequently dissociated by 0.05% trypsin,
and neuronal precursors were expanded and patterned for 4 days
after plating onto polyornithine/laminin-coated plates at a density
of 75,000 cells/cm
2 in N2 medium supplemented with laminin
(1 mg/ml), FGF-2 (10 ng/ml), Shh (500 ng/mL) and murine
FGF8b (100 ng/mL) (stage 4). The cells were subsequently
differentiated in N2 medium containing AA (200 mM) for 10–14
days (stage 5).
Flow Cytometry and Cell Sorting
Cell sorting was performed as previously described [24]. Briefly,
cells were harvested at stage 5 (day 7–10), and stained with
Regional Identity of Adult Brain Neural Stem Cells
PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e19926primary mouse IgM anti-SSEA-1 antibody (0.4 mg/ml; DSHB)
for 20 minutes. Cells were then washed, incubated with Alexa
Fluor 488 fluorescent secondary antibody. FACS sorting was
performed using a FACSAria cell sorter and FACSDiva software
(BD Biosciences). A 100 mm nozzle, sheath pressure of 20–25 psi,
and an acquisition rate of 1,000–2,000 events per second were
used as the standard conditions. Isotype-matched control
antibodies were used to set the gate. Annexin V Apoptosis
Detection Kit (BD Pharmingen) was used according to the
manufacturer’s protocol.
Transplantation into 6-Hydroxydopamine-Lesioned Rats
and Analysis of Drug-Induced Rotational Behaviour
NSC-derived iPSCs, sorted for SSEA1 negative expression,
were resuspended in HBSS containing 1 mg/ml GDNF (Sigma-
Aldrich) at a density of 5‘10
5 cells/mL. 6-OHDA lesioned rats
were grafted into the lesioned striatum with 4 ml of cell suspension
as 2 deposits of 100,000 cells using the following coordinates from
bregma: site 1: AP+0.4; ML -3; DV -5.0; site 2: AP -0.5; ML -3.6;
DV -5.0. Cells were engrafted at a rate of 0.3 ml per minute.
Immunosuppression, anesthesia, transplantation, and analgesia
were performed as previously described [25]. Rotational asym-
metry of 6-OHDA-lesioned rats was analysed after i.p. injection of
amphetamine (4 mg/kg; 90 min) or s.c. injection of apomorphine
(0.1 mg/kg; 40 min) two weeks before transplantation and at 4, 6
and 8 weeks after transplantation. Functionally lesioned rats were
randomly assigned to 2 groups, one control group (n=6) and one
group for the transplantation of differentiated NSC-iPSCs (n=5).
The animals were sacrificed 8 weeks post-transplantation. Brains
were removed, postfixed in 4% paraformaldehyde, equilibrated in
30% sucrose, and sectioned on a freezing microtome in 40-mm
coronal slices.
Immunofluorescent staining and Stereological
Procedures
Immunofluorescent staining was performed as previously
described [24]. The following primary antibodies were used:
sheep/rabbit anti-TH (1:1,000; Pel-Freez Biologicals), rabbit anti-
Pitx3 (1:250, Zymed), mouse anti-En1 (1:50, DSHB), goat anti-
Foxa2 (1:100, Santa Cruz), rabbit/chicken anti b-TubIII (Tuj1,
Covance), rabbit anti-GFAP (1:1000, Dako), mouse anti-SSEA-1
(0.4 mg/ml; DSHB), mouse anti Oct4 (1:100, Santa Cruz
Biotechnology), rabbit anti Nanog (1:100, Bethyl), mouse anti
NeuN (1:1000, Chemicon), mouse anti SSEA1 (1:50, Chemicon),
rabbit anti GAD67 (1:5000, Sigma), rabbit anti GABA (1:5000,
Sigma), mouse anti AFP (1;100, R&D Systems), goat anti
brachyury (1:100, Santa Cruz Biotechnology). Appropriate
fluorescence-labeled secondary antibodies (AlexaFluor; Invitrogen)
were used and nuclei were stained with Hoechst 33342 (5 mg/mL;
Sigma-Aldrich). For light microscopy, biotinylated secondary
antibodies (1:300, Vector Laboratories) were applied to detect
anti-TH antibody, followed by incubation in streptavidin-biotin
complex (Vectastain ABC Kit Elite; Vector Laboratories) for 1 h
and visualized by incubation in 3,39-diaminobenzidine (DAB;
Vector Laboratories). Alkaline phosphatase (AP) staining was
performed using Alkaline Phosphatase.
Detection Kit (Chemicon), according to the manufacturer’s
instructions. Confocal analysis was performed using a Zeiss
LSM510/Meta Station (Thornwood). Stereology was performed
using Stereo Investigator image-capture equipment and soft-
ware (MicroBright-Field,) and a Zeiss Axioplan I fluo-
rescent microscope. Three coverslips were counted for each
immunostaining.
Statistical analysis
For statistical analyses, we used a standard software package
(GraphPad Prism version 4.00). Data are expressed as mean6
SEM. Asterisks identify experimental groups that were significant-
ly different from control groups by t-test, one-way ANOVA, or
two-way ANOVA with a Bonferroni correction for multiple
comparisons (p value, 0.05), where applicable.
Results
Chromatin modifying agents do not alter the
differentiation potential of mouse adult SVZ NSCs
We first investigated whether epigenetic modifications induced
by chromatin modifying agents can increase adult SVZ NSC
responsiveness to the patterning signals that regulate midbrain DA
neuron specification such as sonic hedgehog (Shh) and fibroblast
growth factor 8 (FGF8). We tested the effects of a variety of
chemicals that have been shown to enhance cell dedifferentiation
by promoting an ESC-like state: 5-aza-cytidine (AZA), a DNA
methyltransferase (DNMT) inhibitor; BIX-01294, a G9a histone
methyltransferase inhibitor; valproic acid (VPA) and trichostatin A
(TSA), histone deacetylase inhibitors (HDACi) (Table 1) [26]. The
non-toxic concentration of each chemical was determined by
exposing adult SVZ NSCs to a range of concentrations and
determining cell toxicity by Annexin V/Propidium iodide flow-
cytometry analysis at 24 and 48 hours after treatment (data not
shown). In order to test whether such chromatin modifying agents
increase NSC competency to region-specific neuronal differenti-
ation, NSCs were isolated from the SVZ of adult C57/BL6 mice
and grown as neurospheres in the presence of epidermal growth
factor (EGF) and fibroblast growth factor 2 (FGF-2). In order to
limit the exposure to EGF and FGF-2 that can deregulate the
spatial identity and differentiation potential of neural precursors
[27], only primary neurospheres were used in these experiments.
NSCs were treated with 1 mM AZA, 1 mM BIX-01294, 1 mM
VPA, 100 nM TSA, or 500 nM AZA/100 nM TSA (Table 1) for
72 hours. NSCs were then differentiated upon EGF withdrawal,
using a modified protocol developed for the differentiation of
mouse ESCs to midbrain DA neurons [7,24] (Fig. 1A). In this
protocol, the signaling molecules Shh, FGF-2 and FGF8 induce
ventral midbrain DA neuron patterning of neuronal precursors.
Final differentiation to mature DA neurons is induced by ascorbic
acid (AA) in the absence of growth factors. Differentiation medium
was supplemented with 1 mM AZA, 1 mM BIX-01294, 1 mM
VPA, 100 nM TSA, or 500 nM AZA/100 nM TSA for an
additional 48 hours (Fig. 1A). AZA alone and BIX-01294 at
effective concentrations were found to be too toxic when added
during differentiation, thus were excluded from further studies.
Treatment with HDACi (TSA,VPA) induced a significant increase
of b-TubIII
+ neurons as revealed by immunohistochemistry at day
30 (40.560.5%, 55.2561.6%, 62.564% in untreated, TSA and
Table 1. List of reagents used in the study.
Chemical Function Concentration
AZA DNMT inhibitor 0.5–1 mm
BIX-01294 G9a histone methyltransferase
inhibitor
1 mm
VPA HDAC inhibitor 1 mM
TSA HDAC inhibitor 100 nM
doi:10.1371/journal.pone.0019926.t001
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PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e19926Figure 1. Chromatin modifying agents increase neuronal differentiation of adult mouse SVZ NSCs. (A) Schematic representation of the
experimental design: adult SVZ NSCs were treated with TSA, TSA/AZA or VPA for 5 days and differentiated using a modified protocol developed for
the differentiation of mouse ESCs to midbrain DA neurons. (B) Quantification of b-TubIII
+ neurons and GFAP
+ astrocytes in untreated, TSA-, TSA/AZA-
or VPA-treated cultures. Treatment with TSA and VPA increased the number of b-TubIII
+ neurons, whereas TSA, TSA/AZA and VPA decreased the
number of GFAP
+ astrocytes. Error bars indicate SEM. Three independent experiments were performed in triplicate (** p#0.01, *** p#0.001; One-way
ANOVA). (C) Immunofluorescence staining for neuron-specific class III b-Tubulin (TUJ1) and the glial-specific marker glial fibrillary acidic protein
(GFAP) of untreated, TSA-, TSA/AZA-, and VPA-treated cultures. Nuclei were counterstained with Hoechst. (D) Western blot analysis of differentiated
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respectively) and western blot analysis (Fig. 1B–D). Treatment
with TSA, TSA/AZA and VPA decreased the number of GFAP
+
astrocytes in differentiated cultures at day 30 (6561.9%,
37.2561.8%, 48.3461.5%, 3461.9% in untreated, TSA, TSA/
AZA, and VPA treated cells; p#0.001, p#0.01 and p#0.001
compared to untreated cells) (Fig. 1B–C). Western blot analysis
confirmed the decrease of astrocytic differentiation after treatment
with TSA, TSA/AZA and VPA (Figure 1D). We examined the
expression of tyrosine hydroxylase (TH), the rate-limiting enzyme
of DA synthesis, and other midbrain DA neuronal markers
[engrailed-1 (En1), paired-like homeodomain transcription factor
3 (Pitx3), dopamine transporter (DAT), and nuclear receptor
related 1 (Nurr1)] by immunocytochemistry and RT-PCR at day
16, 26 and 30. Some TH
+ neurons were transiently detected at
day 16 in HDACi treated cultures (data not shown). However,
after the completion of the differentiation protocol (day 30),
differentiated neurons did not express any midbrain DA marker.
We found that differentiated neurons almost exclusively expressed
GAD67, a marker for GABAergic interneurons (Fig. 1E).
Epigenetic modifiers increase the expression of
pluripotency-associated genes and partial demethylation
of Oct4 promoter
We then analysed the expression of pluripotency-associated
genes such as Nanog, Sox2, Oct4, and Klf4 in adult SVZ NSCs at
24 and 48 hours after treatment with VPA, TSA or TSA/AZA.
We found that TSA alone or TSA/AZA significantly induced the
expression of Oct4 and Klf4 at 24 and 48 hours (Fig. 2A). We
investigated the DNA methylation profile of Oct4 promoter. Oct-4
is the master regulator of stem cell pluripotency and differentiation
[28] and the methylation of its promoter drives the conversion
from primitive NSCs (pNSCs) to definitive NSCs (dNSCs) [29],
NSC extracts, untreated or differentiated in the presence of TSA, TSA/AZA or VPA. Two independent experiments were performed in triplicate. Error
bars indicate SEM. (*p#0.05, ** p#0.01; One-way ANOVA). Optical densities of the individual bands were quantified using NIH ImageJ and normalized
by the averaged value of GAPDH. (E) Immunofluorescence staining for b-TubIII (green) and GAD67 (red) of differentiated adult SVZ NSCs treated with
VPA. The majority of b-TubIII
+ neurons co-expressed GAD67. Scale bars: 20 mm (C); 10 mm (E). U, untreated; T, TSA; T/A, TSA/AZA; V, VPA.
doi:10.1371/journal.pone.0019926.g001
Figure 2. Chromatin modifying agents induce the expression of pluripotency-associated genes and promote partial demethylation
of Oct4 promoter in adult SVZ NSCs. (A) SVZ adult NSCs were treated with VPA, TSA, or TSA/AZA and mRNA level of Nanog, Sox2, Oct4 and Klf4
was analysed by qRT-PCR. Values were normalized to the level of b-actin and expressed as relative increase over vehicle-treated cultures. Error bars
indicate SEM. Three independent experiments were performed in triplicate (** p#0.01; # p#0.05; One-way ANOVA). (B) The DNA methylation profile
of 12 CpG sites located in the Oct4 proximal promoter from 2469 to the ATG start codon in mouse ESCs, untreated SVZ NSCs and NSCs treated with
AZA, TSA, VPA or AZA/TSA is shown. The methylated and non-methylated CpG positions are presented as black and white circles, respectively. Ratios
indicate average of methylated to unmethylated sites at the 12 CpG sites6SEM.
doi:10.1371/journal.pone.0019926.g002
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PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e19926Figure 3. Short-term overexpression of Oct4 increases proliferation, self-renewal and neuronal differentiation of adult SVZ NSCs.
(A) Adult SVZ NSCs were isolated from doxycycline (DOX)-inducible Oct4 transgenic mice (rTA-Oct4) and grown as neurospheres in growth medium
with EGF/FGF-2. Oct4 was induced by 2 mg/mL DOX. Fluorescence images of rTA-Oct4 NSCs cultured for 48 hours, with or without DOX, and stained
with an antibody to Oct4. Percentages of Oct4
+ cells are indicated. (B) DOX-dependent induction of Oct-4 protein in adult SVZ NSCs from rTA-Oct4
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differentiation. The methylation status of 12 CpG sites in the Oct4
promoter region (between 470 to the ATG start codon) was
assessed by bisulfite sequencing in mouse ESCs, untreated adult
SVZ NSCs and adult SVZ NSCs treated with AZA, VPA, TSA or
AZA/TSA for 48 hours (Fig. 2B). CpG sites within Oct4 promoter
were mostly unmethylated in mouse ESCs (methylation rate:
2.07561.3%). Conversely, untreated NSCs and AZA-treated
NSCs were highly methylated (methylation rate: 9063.9% and
89.964.9%, respectively). Upon treatment with VPA, TSA or
AZA/TSA we found more unmethylated CpG sites (methylation
rate: 8066.7%, 6463.4%, 6064.1%, respectively) (Fig. 2B).
These data indicate that the chromatin-modifying agents (TSA,
VPA and TSA/AZA) induced de novo expression of pluripotency
genes and partial demethylation of Oct4 promoter in adult SVZ
NSCs. However, these changes were not sufficient to reverse NSC
fate restriction and induce the competency to patterning by
midbrain developmental cues.
The germline factor Oct-4 increases adult SVZ NSC
proliferation and self-renewal
We then examined whether overexpression of Oct-4 can alter
the region-specific differentiation potential of adult SVZ NSCs.
We established neurosphere cultures from the lateral ventricular
walls of rTA/Oct-4 mice [30]. These mice express rtTA-M2, an
optimized form of reverse tetracycline-controlled transactivator
(rtTA) protein directed to multiple tissues by the Gt(ROSA)26Sor
promoter. Following doxycycline (DOX) administration, high
Oct-4 expression is induced in several tissues [30]. In vivo, Oct-4
expression was not originally detected in the brain probably due to
the low penetration of DOX through the blood brain barrier
(BBB) [30]. Therefore, we first tested Oct-4 expression in adult
SVZ NSC cultures derived from rTA/Oct-4 mice. We found that
25-35% of cells expressed Oct-4 as revealed by immunocyto-
chemistry and western-blot analysis 48 hours after DOX induction
(Fig. 3A–B). NSCs that were not exposed to DOX did not show
any detectable Oct-4 expression (Fig. 3A–B). We then determined
the effect of Oct-4 induction on adult SVZ NSC proliferation and
self-renewal. rTA/Oct-4 NSCs were grown as neurospheres in the
presence of EGF and FGF-2, with or without DOX, and
propagated for up to 8 passages. Growth curves revealed increased
long-term proliferation rate in DOX-treated NSCs (Fig. 3C). NSC
self-renewal was assessed by the neurosphere-colony forming
assay. We found more neurosphere-forming cells in DOX-treated
cultures (Fig. 3D).
We then investigated whether Oct-4 overexpression in adult
SVZ NSCs alters their differentiation potential. Oct-4 was induced
by DOX and 72 hours later, NSCs were differentiated upon EGF
withdrawal in the presence of Shh, FGF-2 and FGF8 for 4 days.
DOX was added to the differentiation medium for an additional
48 hours. Cells were then terminally differentiated with AA for
10–14 days (Fig. 3E). Interestingly, we found that Oct-4
overexpression generated more b-TubIII
+ neurons (Fig. 3F–G, J)
and fewer GFAP
+ astrocytes (Fig. 3H–I, J). However, at the end of
differentiation (day 30), almost all b-TubIII
+ neurons co-expressed
the GABA-ergic marker GAD67 (Fig. 3K).
Adult SVZ NSCs are reprogrammed to a pluripotent state
by exogenous Oct4
We overexpressed Oct-4 in rTA-Oct4 SVZ NSC cultures by
DOX and 48 hours later NSCs were plated on mouse embryonic
fibroblasts (MEF) in ESC medium. In order to improve the
efficiency of reprogramming, ESC medium was supplemented
with 0.5 mM VPA for 7–10 days [31] (Fig. 4A). After 5–6 weeks,
we were able to select mouse ESC-like colonies [from now on
termed as NSCs-derived induced pluripotent stem cells (iPSCs)].
We characterized 2 NSC-derived iPSC clones (clones mm3 and
mm4) (Fig. 4B). The estimated reprogramming efficiency of NSCs
was 0.001%. We observed no colonies when VPA was omitted.
NSC-derived iPSCs expressed alkaline phosphates (AP), Nanog
and SSEA-1, and were morphologically indistinguishable from
mouse ESCs (Fig. 4 B–E). As expected, the Oct4 promoter region
of NSC-derived iPSCs was found to be hypomethylated (Fig. 4F).
Interestingly, the Oct4 promoter region of NSCs derived from
iPSCs was hypomethylated compared to adult SVZ NSCs (Fig. 4F
and 2B). These iPSC colonies could be expanded up to 25
passages. We then examined the ability of NSC-derived iPSCs to
differentiate into the three germ layers by embryoid body (EB)
differentiation. EBs derived from NSC-iPSCs expressed markers of
the three germ layers including a-fetoprotein (AFP) (endoderm),
brachyury (mesoderm), and b-TubIII (ectoderm) as determined by
immunocytochemical analysis (Fig. 5 A–D).
Reprogrammed adult SVZ NSCs are successfully
differentiated into midbrain DA neurons
To test whether NSC-derived iPSCs were able to generate DA
neurons in vitro, we differentiated iPSCs according to the mouse
ESC five-stage protocol, with some modifications (Fig. 6A) [7,24].
We induced neural differentiation by EB formation in ITSFn
medium (Fig. 6C). Subsequently, the neural precursors were
expanded in the presence of the growth factors Shh, FGF-2 and
FGF8. Terminal differentiation was induced by growth factor
withdrawal in the presence of AA (Fig. 6D). At day 32, we detected
a total of 30% b-TubIII
+ neurons and a total of 5% TH
+/b-
TubIII
+ neurons (Fig. 6B, E). To assess neuronal regional
specification, we double-labeled TH-positive neurons with anti-
body against Pitx3 and En1, markers typically expressed in
midbrain DA neurons (Fig. 6 G–H). Importantly, the vast majority
of TH-positive neurons stained positive for these midbrain
markers, suggesting their proper midbrain regional specification
transgenic mice determined by Western blot analysis. Mouse embryonic stem cells (mESC) were used as control. GAPDH was used as loading control.
(C) Growth curves of DOX-induced and -uninduced adult SVZ NSCs. Time points represent average values from triplicate measurements and their
standard deviations (* p#0.05, Two-way ANOVA with post hoc analysis by Bonferroni test). (D) Clonal analysis of SVZ adult NSCs after Oct4 induction.
NSCs were grown as neurospheres and treated with DOX or left untreated. After dissociation, single cells were replated and the total number of
neurospheres with a diameter .100 mm was assessed and expressed as % over plated cells (** p#0.01, t-test). Error bars indicate SEM. (E) Schematic
representation of the experimental design: SVZ adult NSCs were isolated from rTA-Oct4 transgenic mice and grown as neurospheres in growth
medium with EGF/FGF-2, with or without DOX. Forty-eight hours after Oct4 induction, neurospheres were dissociated and replated in differentiation
medium with Shh, FGF8, FGF-2, with or without DOX. DOX was withdrawn after 48 hours. Cells were finally differentiated with ascorbic acid (AA).
(F–I) Immunofluorescence staining for b-TubIII (green, F–G) and GFAP (green, H–I) of adult SVZ NSCs differentiated with or without Oct4 induction.
Nuclei were counterstained with Hoechst. (J) Quantification of b-TubIII
+ neurons and GFAP
+ astrocytes in untreated and DOX-treated neuronal
cultures. Error bars indicate SEM. Three independent experiments were performed in triplicate. (*** p#0.001; t-test). (K) Immunofluorescence staining
for b-TubIII (green) and GAD67 (red) of differentiated adult SVZ NSCs upon Oct4 induction. The majority of b-TubIII
+ neurons co-expressed GAD67.
Scale bars: 50 mm (F–I); 10 mm (K).
doi:10.1371/journal.pone.0019926.g003
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TH and GABA, a marker typically expressed in OB glomerular
interneurons (Fig. 6F). qRT-PCR analysis further confirmed
expression levels of midbrain DA markers in differentiated
cultures: DAT, PITX3, En1, G-protein-activated inwardly
rectifying potassium channel subunit (Girk2), vesicular mono-
amine transporter (VMAT), aldehyde dehydrogenase 2 (ALDH),
Calbindin and Nurr1 (Fig. 6I).
Midbrain DA neurons from reprogrammed adult SVZ
NSCs are successfully grafted and reverse drug-induced
behaviour in parkinsonian rats
To further analyse the DA fate potential of NSC-derived iPSCs
in vivo, we explored the ability of differentiated neurons to survive,
integrate and reinnervate the host striatum of 6-hydroxydopamine
(6-OHDA)-lesioned rats, a rodent animal model of PD. Adult
Figure 4. SVZ adult NSCs are reprogrammed to pluripotent stem cells by overexpression of Oct-4. (A) Schematic representation of the
experimental design: SVZ adult NSCs were isolated from rTA-Oct4 transgenic mice and grown as neurospheres. Oct4 was induced by DOX, and
48 hours later, NSCs were plated on mouse feeder cells (MEF) in ESC medium with 0.5 mM VPA. ESC-like colonies were picked 30–40 days after DOX
induction. (B) Phase contrast image showing ESC-like morphology of NSC-derived iPSCs (clone mm3) on MEF. (C–E) Colonies expressed alkaline
phosphatase (AP) and stained positive for Nanog and SSEA-1. (F) Methylation analysis of the Oct4 promoter region. White circles indicate
unmethylated and black circles methylated CpGs in the Oct4 promoter of mouse ESCs, reprogrammed NSCs and NSCs derived from iPSCs (stage 3,
day 11). Scale bars: 100 mm.
doi:10.1371/journal.pone.0019926.g004
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neurons as described above and transplanted into the striatum of
6-OHDA-lesioned rats. Animals received a striatal graft of 2610‘5
differentiated cells. In order to avoid tumor formation, SSEA1+
cells were eliminated by cell sorting FACS prior to transplantation
(Figure S1). Analysis of amphetamine-induced behaviour showed a
significant reduction of ipsilateral rotations at 8 weeks after
transplantation (Fig. 7G), indicating significant restoration of the
6-OHDA lesion. We found that rats transplanted with differen-
tiated NSC-derived iPSCs showed a significantly reduced number
of apomorphine-induced rotations 8 weeks after engraftment,
when compared to the non-transplanted rats (Fig. 7H). Eight
weeks after surgery, the animal brains were prepared for
morphological analysis. TH staining showed that animals
displaying improvement in the behavioural assays had grafts
containing large numbers of DA neurons (Fig. 7A–D). Important-
ly, the transplanted neurons expressed the midbrain DA marker
Pitx3 and Foxa2 (Fig. 7E–F). TH-immunoreactive fibres were
found to extend into the parenchyma of the host striatum
(Fig. 7B,C).
Discussion
NSCs acquire a regional identity already at the formation of the
neural plate during embryogenesis [32,33]. Therefore, fetal and
adult NSCs have passed crucial checkpoints that restrict their
developmental capacity to generate region-specific neuronal
subtypes.
Epigenetic modifications (i.e. histone code and DNA methyla-
tion) play a critical role in regulating adult NSC differentiation and
fate determination [34]. Here we investigated whether epigenetic
remodeling induced by chromatin-modifying agents can reverse
adult SVZ NSC developmental restriction and enable their
differentiation into region-specific neuronal subtypes such as
midbrain DA neurons. Chromatin remodeling factors can
improve the induction of an ESC-like state and have been
extensively used to enhance dedifferentiation of somatic cells to the
pluripotent state [31]. We showed that chromatin-modifying
agents (TSA and TSA in combination with AZA) reactivate
specific pluripotency-associated genes such as Oct4 and Klf-4 in
adult SVZ NSCs. These agents induced partial demethylation of
Oct4 promoter, thus promoting a dedifferentiation toward a
primitive neural stage. We observed an increased neuronal
differentiation, paralleled by a decreased number of astrocytes in
treated NSC cultures. However, these modifications were not
sufficient to reverse the resistance of NSCs to the patterning signals
that regulate midbrain DA development, since the majority of
differentiated neurons showed a GABAergic phenotype. Previous
reports have shown the derivation of iPSCs from NSCs [35,36].
Specifically, the overexpression of Oct-4 alone induces the
reprogramming of NSCs obtained from mouse whole brain and
fetal human telencephalon NSCs [37,38]. In the current work we
show for the first time that Oct4 overexpression in association with
the chromatin-modifying agent VPA induced adult SVZ NSC
reprogramming into iPSCs. Such Oct4-reprogrammed NSCs were
then successfully differentiated into midbrain DA neurons.
Figure 5. NPC-derived iPSCs can be differentiated into three germ layers in vitro. NSC-derived iPSCs were differentiated into three germ
layers by embryoid body (EB) differentiation. (A) In vitro EB formation. (B–D) EBs expressed markers of the three germ layers including a-fetoprotein
(AFP) (endoderm), brachyury (mesoderm), and b-TubIII (ectoderm). Scale bars: 25 mm (A–C); 50 mm (D).
doi:10.1371/journal.pone.0019926.g005
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reprogrammed adult SVZ NSCs generated functional midbrain
DA neurons that successfully improved the motor behavioural
deficits in a rodent model of PD. Such functional motor
behavioural recovery in this model is further significant evidence
for the correct subtype of DA neurons generated from NSC-
derived iPSCs.
With respect to functional cell therapy for the motor symptoms
of PD, it is critical to obtain DA neurons that have the molecular
properties of midbrain DA neurons [6]. Both substantia nigra (SN-
A9) and ventral tegmental area (VTA-A10) DA neurons contribute
to widespread and dense axonal arborization [39], and SN-A9 DA
neurons are responsible for appropriate striatal reinnervation and
behavioural motor recovery in rodent models of PD [5,6].
However, no studies have reported successful in vitro differenti-
ation of adult SVZ NSCs into midbrain DA neurons. When grown
as neurospheres and differentiated according to the most dedicated
differentiation culture protocols, fetal and adult NSCs only
generate a small number of TH
+ neurons [40]. Furthermore,
such differentiated TH
+ neurons do not express markers of
midbrain DA neurons [41,42], which is the required cell type for
grafting and appropriate striatal reinnervation in PD. In vivo,
mobilization of SVZ endogenous precursor cells has been
envisaged as a promising alternative to cell transplantation for
the treatment of neurodegenerative diseases including PD [43].
Therefore, different approaches have been tested to promote the
differentiation of adult SVZ NSCs to midbrain DA neurons and
endogenous NPC proliferation in order to achieve tissue repair
Figure 6. Reprogrammed adult NSCs can be differentiated into midbrain DA neurons. (A) NSC-derived iPSCs were differentiated into DA
neurons according to the five-stage protocol. Neural differentiation was induced by EB formation in ITSFn medium. Subsequently, the neural
precursors were expanded in the presence of the growth factors FGF-2, FGF8, and Shh. Terminal differentiation was induced by growth factor
withdrawal in the presence of ascorbic acid. (B) Graphs indicate the percentage of cells that stained positive for b-TubIII and TH, relative to nuclear
Hoechst staining. Error bars indicate SEM. Three independent experiments were performed in triplicate. (C) Brightfield images showing EB-derived
FGF2-responsive neural precursor cells. (D) Brightfield microphotographs of differentiated NSC-derived iPSCs, 7 days after growth factor withdrawal.
(E) Immunofluorescence staining of neuronal cultures derived from NSC-derived iPSCs for b-TubIII (green) and TH (red). (F) Immunofluorescence
staining for TH (red) and GABA (green), a marker typically expressed in olfactory bulb (OB) glomerular interneurons. Nuclei were counterstained with
Hoechst. (G–H) Confocal images of neuronal cultures stained for b-TubIII (green) (G), TH (red) (G–H), En1 (blue) (G) and Pitx3 (green) (H). (I)
Quantitative RT-PCR analysis of midbrain transcription factors, DA neurotransmission markers (TH, DAT, Pitx3, En1, Girk2, VMAT, ALDH, Nurr1) and
calbindin in differentiated NSC-derived iPSCs. cDNA was isolated from differentiated adult NSC-derived iPSCs, and values were normalized to the level
of b-actin. Error bars indicate SEM. Three independent experiments were performed in triplicate. Scale bar: 200 mm (C–D); 50 mm (E–F); 20 mm (G–H).
ITSFn, insulin/transferrin/selenium/fibronectin.
doi:10.1371/journal.pone.0019926.g006
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erative diseases [9,10,11,12,44]. However, there is no evidence
that such strategies promote the generation of functional midbrain
DA neurons that integrate into the injured or naı ¨ve nigrostriatal
DA system [13,14,15].
Adult NSCs are resistant to the signaling molecules (Shh, FGF8)
that control the development of midbrain and hindbrain [45]. The
precise mechanism by which such restriction is controlled and
maintained in adult SVZ NSCs is still poorly understood. During
mouse development, the earliest NSCs can be isolated starting at
embryonic day 5.5 (E5.5) [32]. These pNSCs retain ESC
characteristics such as high Oct-4 expression and in vitro LIF-
dependence [46]. pNSCs are highly responsive to regionalization
cues, allowing the efficient generation of region-specific neuronal
subtypes. LIF-dependent NSCs with similar antigenic and
functional properties can also be isolated from E5.5–7.5 mouse
embryos [47]. Between embryonic day 7.5 (E7.5) and E8.5, germ
cell nuclear factor (GNFC)-mediated Oct4 promoter methylation
drives the conversion from pNSCs to dNSCs [29]. In the
developing neuroectoderm and NSC cultures, such transition
from pNSCs to dNSCs restricts the potential of dNSCs to form
non-neural cell types and their capacity to generate region-specific
neuron populations.
Interestingly, we found that Oct-4 overexpression, without
reprogramming to an ESC state, increased NSC self-renewal and
long-term proliferation in the presence of EGF and FGF-2. In
addition, we showed that Oct4 overexpression increases neuronal
differentiation of NSC cultures in the presence of Shh, FGF-2 and
FGF8. However, our data indicate that such short-term Oct-4
overexpression alone does not confer competence for adult SVZ
NSC midbrain regionalization. In contrast, long-term overexpres-
sion (30–40 days) of Oct-4 in adult SVZ NSCs grown on MEFs in
ESC medium with LIF induced complete dedifferentiation to a
pluripotent state. Only after Oct-4 induced reprogramming to a
pluripotent state were adult SVZ NSCs successfully patterned to
midbrain DA neurons.
Figure 7. DA neurons from Oct4 reprogrammed adult NSCs integrate into the striatum of 6-OHDA lesioned parkinsonian rats and
improve behavioural deficits. (A) A low-power overview of an iPSC cell graft 8 weeks after transplantation stained with an antibody against TH
(dark brown). (B–C) Higher magnification of a NSC-derived iPSC graft showing TH-positive soma and the reinnervation of the surrounding host
striatum by donor-derived neurites. The dashed line indicates the edge of the graft. (D–F) Confocal analysis of NSC-derived iPSC grafts, 8 weeks post-
transplantation, showed that most grafts contained midbrain DA neurons. The grafted TH-positive cells (red) were colabeled with antibodies against
NeuN (green) (D), Pitx3 (green) (E) and FOXA2 (green) (F). (G–H) DA neurons from NSC-derived iPSCs reversed amphetamine- and apomorphine-
induced rotational behaviour upon engraftment into 6-OHDA-lesioned rats. Animals were analysed for amphetamine- and apomorphine-induced
rotational behaviour before and 4, 6, and 8 weeks post transplantation. Graphs show mean values6SEM. (* p#0.05, Two-way ANOVA with post hoc
analysis by Bonferroni test). Scale bars: 200 mm (A–B); 100 mm (C); 20 mm (D–E); 10 mm (F).
doi:10.1371/journal.pone.0019926.g007
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In summary, we show that epigenetic modifications are not
sufficient to reverse the resistance of SVZ NSCs to the patterning
signals that regulate midbrain regional specification. Such
modifications do not promote the dedifferentiation of adult SVZ
dNSCs toward a primitive neural stage. The current work
describes for the first time the reprogramming of adult SVZ
NSCs by means of Oct4 overexpression and provides the first
evidence that functional midbrain DA neurons can be derived
from Oct4-reprogrammed adult SVZ NSCs. These results indicate
that the complex and precise regulatory processes responsible for
the regional specification of adult NSCs are irreversible, and
further de-differentiation steps are required to regain the
competency to generate region-specific neuronal phenotypes.
These findings have major fundamental scientific and practical
implications for regenerative neuroscience.
Supporting Information
Figure S1 Elimination of SSEA1+ cells from NSC-
derived iPSC neuronal cultures by cell sorting. (A–C)
Neuronal NSC-derived iPSC cultures after sorting based on
SSEA1 expression. After sorting, cells were replated onto tissue
culture dishes in N2 medium with AA. Three days after sorting,
SSEA1
2 sorted cells displayed mostly neuronal morphology,
whereas the SSEA1
+ sorted cells exhibited an undifferentiated ES
cell morphology. (D–F) Immunofluorescence images of neuronal
cultures 3 days after sorting stained for b-TubIII (green), TH (red)
and SSEA1 (blue). Scale bars: 50 mm (A–F).
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